Breezing Med (FDA-cleared) is the best tool for managing obesity and related type 2 diabetes.
Research indicates “the lifetime diabetes risk in men older than 18 years increases from 7% to 70% when BMI increases from less than 18.5 kg/m to more than 35 kg/m. Similarly, the lifetime diabetes risk in females increases from 12% to 74% with the same BMI values. Weight reduction leads to a significant reduction in the incidence of diabetes in at-risk populations.”
Source:
https://lnkd.in/gGrwZAFm
Breezing Med can be used to help physicians in lifestyle management for patients diagnosed with type 2 diabetes, providing medical weight loss meal plan and exercise programs, and post surgery patient monitoring.